Home / Pharma news / Sun Pharma strong and healthy

Sun Pharma strong and healthy

The $4.6 billion Sun Pharmaceutical IndustriesBSE 0.23 % has been at the forefront of the Indian pharma growth story, which has evolved from the sale of low-cost medicines in the largest markets to competing with the largest generic companies globally. Pioneering strategy and diligent execution has enabled the company to become the world’s fifth-largest specialty generic company in 30 years of operations. Inorganic expansion with a track record of turning around distressed assets has significant ..


Check Also

Diabetes-Silent Killer

The total estimated cost of diagnosed diabetes in 2017 was $327 billion, including $237 billion ...

%d bloggers like this: